Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:10 AM
Ignite Modification Date: 2025-12-25 @ 12:10 AM
NCT ID: NCT00957658
Eligibility Criteria: Inclusion Criteria: 1. Patient is a candidate for a primary total hip replacement. 2. Patient has primary diagnosis of osteoarthritis (OA). 3. Male and non-pregnant female patients ages 18 to 90. 4. Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form. 5. Patient willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation. 6. Patient capable of undergoing a pre-op central DXA (dual-energy x-ray absorptiometry) scan for a bone mineral density (BMD) reading. Exclusion Criteria: 1. Patient has an active infection within the affected hip joint. 2. Patient requires a revision surgery of a previously implanted total hip arthroplasty or hip fusion to the affected joint. 3. Patient who is morbidly obese, Body Mass Index (BMI) \> 40. 4. Patient has a neuromuscular or neurosensory deficiency, which limits ability to evaluate the safety and efficacy of the device. 5. Patient has the following diagnosed systemic diseases: Paget's disease, renal osteodystrophy, lupus erythematosus, rheumatoid arthritis, metabolic bone disease and sickle cell anemia. 6. Patient is immunologically suppressed or receiving chronic steroids more than 30 days. Patients receiving oral or IV steroids within one month of surgery. 7. Patient is a prisoner.
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 90 Years
Study: NCT00957658
Study Brief:
Protocol Section: NCT00957658